Galectin Therapeutics (GALT) Interest & Investment Income (2010 - 2026)
Galectin Therapeutics' Interest & Investment Income was $28,000 in Q2 2026, up 7.7% from $26,000 a year earlier but down 22.2% from the prior quarter.
Powered by 
Analysis
Galectin Therapeutics (GALT) Interest & Investment Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Galectin Therapeutics' Interest & Investment Income was $128,000 through Jun 30, 2026, down 46.2% year-over-year; for FY2025, it came in at $126,000, down 62.7% from FY2024.
- Interest & Investment Income shows a five-year compound annual growth rate of 13.8% (FY2020 to FY2025).
- In earlier years, Interest & Investment Income was $338,000 in FY2024 (+47.0%), $230,000 in FY2023 (+342.3%), $52,000 in FY2022 and $3,000 in FY2021 (-95.5%).
- Quarterly Interest & Investment Income has moved between $1,000 (Q3 2021) and $93,000 (Q3 2024) over five years.
- Compared with a year earlier, Interest & Investment Income was higher in four of the last eight quarters, with an average decline of 22.2%.
- The best year-over-year quarter for Interest & Investment Income over five years was Q3 2023 (growth of 244.4%); the worst was Q3 2021 (a decline of 80.0%).
- Per Business Quant data, GALT's Interest & Investment Income in the three quarters before Q2 2026 was $36,000 (Q1 2026), $25,000 (Q4 2025) and $39,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Galectin Therapeutics | 258.62 Mn | 258.62 Mn | - | 28,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28,000.00 |
| Mar 31, 2026 | 36,000.00 |
| Dec 31, 2025 | 25,000.00 |
| Sep 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 84,000.00 |
| Sep 30, 2024 | 93,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | 80,000.00 |
| Dec 31, 2023 | 74,000.00 |
| Sep 30, 2023 | 62,000.00 |
| Jun 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 44,000.00 |
| Dec 31, 2022 | 30,000.00 |
| Sep 30, 2022 | 18,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 1,000.00 |
API Access
Galectin Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GALT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "GALT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GALT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();